|
Home > Articles
Molecular imaging in oncology
Abstract
Cancer is a genetic disease that manifests in loss of normal cellular homeostatic mechanisms. The biology and therapeutic modulation of neoplasia occurs at the molecular level. An understanding of these molecular processes is therefore required to develop novel prognostic and early biomarkers of response. In addition to clinical applications, increased impetus for the development of such technologies has been catalysed by pharmaceutical companies investing in the development of molecular therapies. The discipline of molecular imaging therefore aims to image these important molecular processes in vivo. Molecular processes, however, operate at short length scales and concentrations typically beyond the resolution of clinical imaging. Solving these issues will be a challenge to imaging research. The successful implementations of molecular imaging in man will only be realised by the close co-operation amongst molecular biologists, chemists and the imaging scientists.
Author
A S K Dzik-Jurasz
Contact Details
Corresponding address:
A S K Dzik-Jurasz,
GlaxoSmithKline,
891-995 Greenford Road,
Middlesex, UB6 0HE, UK.
Reference
ICIS Cancer Imaging volume 4
DOI: 10.1102/1470-7330.2004.0060
Date Posted
21 October 2004
Screen PDF
Size
772.19 KB
Minimum Estimated Download Times
ADSL 2Mb/s (Broadband): |
3 seconds |
ADSL 512Kb/s (Broadband): |
12 seconds |
64 Kb/s (ISDN): |
1 minute 36 seconds |
33.3 Kb/s (Typical Modem): |
3 minutes 5 seconds |
Print PDF
Size
4.81 MB
Minimum Estimated Download Times
ADSL 2Mb/s (Broadband): |
19 seconds |
ADSL 512Kb/s (Broadband): |
1 minute 17 seconds |
64 Kb/s (ISDN): |
10 minutes 16 seconds |
33.3 Kb/s (Typical Modem): |
19 minutes 44 seconds |
|
